Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $428.76 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $167.37 | 9 | $0 (2022) |
| ABBVIE INC. | $106.52 | 5 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $97.75 | 2 | $0 (2022) |
| Medtronic USA, Inc. | $34.42 | 2 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $22.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.00 | 3 | ABBVIE INC. ($36.30) |
| 2023 | $47.87 | 2 | ABBVIE INC. ($47.87) |
| 2022 | $129.81 | 4 | Ipsen Biopharmaceuticals, Inc ($78.76) |
| 2021 | $18.79 | 1 | Allergan, Inc. ($18.79) |
| 2020 | $34.54 | 2 | Allergan, Inc. ($18.67) |
| 2019 | $118.62 | 6 | Allergan Inc. ($81.08) |
| 2018 | $20.13 | 1 | Allergan Inc. ($20.13) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Musculoskeletal | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $78.76 | General |
| Category: Neurology | ||||||
| 02/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/18/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: SPASTICITY | ||||||
| 10/13/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: SPASTICITY | ||||||
| 02/27/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: SPASTICITY | ||||||
| 01/08/2020 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Drug Infusion Systems | ||||||
| 12/04/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Drug Infusion Systems | ||||||
| 08/08/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neurology | ||||||
| 01/24/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2018 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: SPASTICITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 566 | 5,121 | $332,495 | $91,449 |
| 2022 | 13 | 517 | 8,903 | $409,129 | $109,804 |
| 2021 | 19 | 651 | 7,257 | $384,003 | $105,740 |
| 2020 | 13 | 624 | 1,351 | $371,300 | $97,834 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 25 | 30 | $8,160 | $2,372 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 35 | $5,950 | $2,272 | 38.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 14 | 14 | $6,342 | $1,514 | 23.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 47 | $5,640 | $1,427 | 25.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 19 | 28 | $13,412 | $1,282 | 9.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 18 | $2,898 | $746.46 | 25.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 13 | 6,300 | $107,100 | $30,361 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 174 | 342 | $75,582 | $19,296 | 25.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 124 | $28,768 | $11,756 | 40.9% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 69 | 114 | $31,008 | $9,208 | 29.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 46 | $28,566 | $6,980 | 24.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 26 | 26 | $19,110 | $4,634 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 43 | 54 | $17,226 | $4,387 | 25.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 56 | $9,520 | $4,033 | 42.4% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 22 | 22 | $13,310 | $3,289 | 24.7% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Office | 2021 | 13 | 20 | $12,440 | $2,258 | 18.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 17 | 18 | $8,154 | $2,046 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 20 | 20 | $6,540 | $1,680 | 25.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $4,302 | $1,514 | 35.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 17 | 17 | $3,791 | $969.17 | 25.6% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 16 | 16 | $2,624 | $865.95 | 33.0% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 16 | 19 | $9,101 | $827.08 | 9.1% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 11 | 16 | $2,848 | $604.80 | 21.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 13 | $2,093 | $541.97 | 25.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 16 | $1,920 | $486.88 | 25.4% |
About Dr. Somkiat Hemtasilpa, M.D
Dr. Somkiat Hemtasilpa, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013974237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Somkiat Hemtasilpa, M.D has received a total of $428.76 in payments from pharmaceutical and medical device companies, with $59.00 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($428.76).
As a Medicare-enrolled provider, Hemtasilpa has provided services to 2,358 Medicare beneficiaries, totaling 22,632 services with total Medicare billing of $404,827. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/01/2006
- Last Updated 03/26/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1013974237
Products in Payments
- BOTOX (Biological) $172.68
- DYSPORT (Drug) $97.75
- BOTOX (Drug) $81.08
- SYNCHROMED (Device) $34.42
- Xeomin (Biological) $22.70
- BOTOX - SPASTICITY (Drug) $20.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Li-Hong Lu, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,263
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Paul Brockman, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $435.07
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26